Brief: HOOKIPA Pharma Announces Publication Of Preclinical Data Of Hepatitis B Virus Therapeutic Vaccine Developed With Gilead Sciences
18/10/2023 12:06
Oct 18 (Reuters) - HOOKIPA Pharma Inc HOOK.O :
* HOOKIPA PHARMA ANNOUNCES PUBLICATION OF PRECLINICAL DATA
OF
HEPATITIS B VIRUS (HBV) THERAPEUTIC VACCINE DEVELOPED IN
COLLABORATION WITH GILEAD SCIENCES
* HOOKIPA PHARMA INC - GILEAD-LED PHASE 1 CLINICAL TRIAL TO
EVALUATE SAFETY AND TOLERABILITY OF HB-400 IN HUMANS IS ONGOING
Source text for Eikon: ID:nGNX50jh46
Further company coverage: HOOK.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)